EQT
51
-3
NOV
52
-5
BBY
52
6
ROST
57
-3
YUM
43
-6
MCD
52
-5
TEL
60
-8
COP
57
-2
STT
64
2
SCHW
62
-2
WBA
43
-4
HRL
35
-3
TXT
53
-3
NWS
75
-4
EOG
56
-2
JBHT
56
-3
GD
41
-4
BMY
55
-8
JNPR
50
-6
CFG
74
2
EQT
51
-3
NOV
52
-5
BBY
52
6
ROST
57
-3
YUM
43
-6
MCD
52
-5
TEL
60
-8
COP
57
-2
STT
64
2
SCHW
62
-2
WBA
43
-4
HRL
35
-3
TXT
53
-3
NWS
75
-4
EOG
56
-2
JBHT
56
-3
GD
41
-4
BMY
55
-8
JNPR
50
-6
CFG
74
2
Financhill
Back

RxSight Vs. Neurogene Industry Stock Comparison

Sell
6

RXST
RxSight

Last Price:
45.05
Seasonality Move:
35.42%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
6
RxSight (RXST) is a Sell

Is RxSight a Buy, Sell or Hold?

  • The current RxSight [RXST] share price is $45.05. The Score for RXST is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • RXST is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RXST Stock Price Chart

What is RxSight's stock price today?

  • The RxSight share price today is $45.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

RXST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.38 Sell
Relative Strength Index (14 RSI): 36.53 Sell
Chaikin Money Flow: -372565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47 - 52.04) Sell
Bollinger Bands (100): (46.86 - 54.76) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

RXST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.4 Sell
20-day SMA: 49.34 Sell
50-day SMA: 50.37 Sell
200-day SMA: 52.83 Sell
8-day EMA: 46.63 Sell
20-day EMA: 48.49 Sell
50-day EMA: 49.9 Sell
200-day EMA: 48.98 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

RxSight Earnings Growth & RXST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.29 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

RxSight Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):